Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy

por Lai, Kenneth K. H., Aljufairi, Fatema Mohamed Ali Abdulla, Li, Chi Lai, Ngai, Amanda K. Y., Yeung, Carly S. K., Fong, Ryan H. Y., Yip, Wilson W. K., Young, Alvin L., Pang, Chi Pui, Chong, Kelvin K. L.
Publicado 2023